TY - JOUR
T1 - A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression
AU - Cerutti, Janete M.
AU - Delcelo, Rosana
AU - Amadei, Marcelo João
AU - Nakabashi, Claudia
AU - Maciel, Rui M.B.
AU - Peterson, Bercedis
AU - Shoemaker, Jennifer
AU - Riggins, Gregory J.
PY - 2004/4
Y1 - 2004/4
N2 - Accurate diagnosis of thyroid tumors is challenging. A particular problem is distinguishing between follicular thyroid carcinoma (FTC) and benign follicular thyroid adenoma (FTA), where histology of fine-needle aspirates is not conclusive. It is often necessary to remove healthy thyroid to rule out carcinoma. In order to find markers to improve diagnosis, we quantified gene transcript expression from FTC, FTA, and normal thyroid, revealing 73 differentially expressed transcripts (P ≤ 0.0001). Using an independent set of 23 FTCs, FTAs, and matched normal thyroids, 17 genes with large expression differences were tested by real-time RT-PCR. Four genes (DDIT3, ARG2, ITM1, and C1orf24) differed between the two classes FTC and FTA, and a linear combination of expression levels distinguished FTC from FTA with an estimated predictive accuracy of 0.83. Furthermore, immunohistochemistry for DDIT3 and ARG2 showed consistent staining for carcinoma in an independent set 59 follicular tumors (estimated concordance, 0.76; 95% confidence interval, [0.59, 0.93]). A simple test based on a combination of these markers might improve preoperative diagnosis of thyroid nodules, allowing better treatment decisions and reducing long-term health costs.
AB - Accurate diagnosis of thyroid tumors is challenging. A particular problem is distinguishing between follicular thyroid carcinoma (FTC) and benign follicular thyroid adenoma (FTA), where histology of fine-needle aspirates is not conclusive. It is often necessary to remove healthy thyroid to rule out carcinoma. In order to find markers to improve diagnosis, we quantified gene transcript expression from FTC, FTA, and normal thyroid, revealing 73 differentially expressed transcripts (P ≤ 0.0001). Using an independent set of 23 FTCs, FTAs, and matched normal thyroids, 17 genes with large expression differences were tested by real-time RT-PCR. Four genes (DDIT3, ARG2, ITM1, and C1orf24) differed between the two classes FTC and FTA, and a linear combination of expression levels distinguished FTC from FTA with an estimated predictive accuracy of 0.83. Furthermore, immunohistochemistry for DDIT3 and ARG2 showed consistent staining for carcinoma in an independent set 59 follicular tumors (estimated concordance, 0.76; 95% confidence interval, [0.59, 0.93]). A simple test based on a combination of these markers might improve preoperative diagnosis of thyroid nodules, allowing better treatment decisions and reducing long-term health costs.
UR - http://www.scopus.com/inward/record.url?scp=2142702917&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2142702917&partnerID=8YFLogxK
U2 - 10.1172/JCI19617
DO - 10.1172/JCI19617
M3 - Article
C2 - 15085203
AN - SCOPUS:2142702917
SN - 0021-9738
VL - 113
SP - 1234
EP - 1242
JO - Journal of Clinical Investigation
JF - Journal of Clinical Investigation
IS - 8
ER -